WallStSmart

Global Mofy Metaverse Limited Ordinary Shares (GMM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 363% more annual revenue ($258.90M vs $55.94M). ZEPP leads profitability with a -15.5% profit margin vs -34.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

GMM

Avoid

35

out of 100

Grade: F

Growth: 7.3Profit: 3.0Value: 6.7Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GMMUndervalued (+76.6%)

Margin of Safety

+76.6%

Fair Value

$5.65

Current Price

$1.27

$4.38 discount

UndervaluedFair: $5.65Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GMM2 strengths · Avg: 10.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
36.2%10/10

Revenue surging 36.2% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

GMM4 concerns · Avg: 2.5/10
Market CapQuality
$69.62M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.5%3/10

Operating margin of 4.5%

Return on EquityProfitability
-35.9%2/10

ROE of -35.9% — below average capital efficiency

EPS GrowthGrowth
-83.9%2/10

Earnings declined 83.9%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : GMM

The strongest argument for GMM centers on Price/Book, Revenue Growth. Revenue growth of 36.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : GMM

The primary concerns for GMM are Market Cap, Operating Margin, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 35/100) and 43.0% revenue growth. GMM offers better value entry with a 76.6% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Global Mofy Metaverse Limited Ordinary Shares

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Global Mofy Metaverse Limited, provides virtual content production, digital marketing, and digital assets development services for the metaverse industry in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?